Citadel Advisors - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is and the CUSIP is 87162T956. A total of 3 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2015$12,000
-65.7%
35,400
+76.1%
0.00%
Q3 2015$35,000
-34.0%
20,100
-15.2%
0.00%
Q2 2015$53,000
+32.5%
23,700
+14.5%
0.00%
Q1 2015$40,000
-27.3%
20,700
+0.5%
0.00%
Q4 2014$55,000
-17.9%
20,600
-6.8%
0.00%
Q3 2014$67,000
-15.2%
22,100
+13.9%
0.00%
Q2 2014$79,000
+23.4%
19,400
+31.1%
0.00%
Q1 2014$64,000
-52.2%
14,800
-42.2%
0.00%
Q4 2013$134,000
+19.6%
25,600
+44.6%
0.00%
Q3 2013$112,000
-68.6%
17,700
-75.3%
0.00%
-100.0%
Q2 2013$357,00071,6000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 147,800$330,0000.01%
SIMPLEX TRADING, LLC 8$6,0000.00%
Citadel Advisors 23,700$53,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders